EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL
about
The emerging roles of exosomes in leukemogeneisParkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution AnalysisIdentification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA ComponentsFedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver.Therapeutic applications of extracellular vesicles: clinical promise and open questions.RNAs in Epstein-Barr virions control early steps of infection.Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery.In vitro immunotoxicity assessment of culture-derived extracellular vesicles in human monocytesExtracellular vesicles and their convergence with viral pathways.Viral effects on the content and function of extracellular vesicles.Non-viral nucleic acid delivery methods.Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery.The enigmatic seminal plasma: a proteomics insight from ejaculation to fertilization.
P2860
Q26748606-A8D06EB5-A567-4A19-864B-21DB7D8911FDQ27932080-CADBC547-27BA-4D0D-9EAD-BB8FD17D8CF7Q28075450-2C380FF9-9F23-42D2-ACA4-0BF17B2F5663Q28554266-9D4DC1BD-0079-4564-AC8A-EA807A9DACCAQ34037648-0BA8F8DC-A7E4-44C4-A60D-62828B646C3AQ35654719-24DE99F4-CB6B-4682-979D-C6C3EA21AAF1Q35991530-9AE9DF00-BDA1-4012-8E81-C8D6F03E8873Q36422761-7F92E0FD-0AD1-4E5B-A15C-6F9251CD6C6DQ36902474-FE7A5DBD-9158-4D0D-82B6-BC7B3D2578D9Q37150093-49BF42C1-FD3F-4B04-9D69-C0CB75F3C640Q38034222-2407E9BF-28C5-4B6A-BDBA-25D590194739Q38666881-201F1D63-6D85-4905-ACA6-44624F51F8EFQ38980476-BB4748D1-2462-41EE-8BAC-E9F995CCE81DQ52726716-02D52E32-39E2-4648-8E7A-56E9800DA5C0Q54966167-759B8F05-4633-4AA6-A087-CDC886E45948
P2860
EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@ast
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@en
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@nl
type
label
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@ast
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@en
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@nl
prefLabel
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@ast
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@en
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@nl
P2093
P2860
P1433
P1476
EBV-gp350 confers B-cell tropi ...... ion for the treatment of B-CLL
@en
P2093
Ralph Mocikat
Reinhard Zeidler
Romana Ruiss
Simon Jochum
Wolfgang Hammerschmidt
P2860
P304
P356
10.1371/JOURNAL.PONE.0025294
P407
P577
2011-10-10T00:00:00Z